As detailed in a separate post, bit.bio have developed a new, innovative technology named opti-ox™ to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering .

Here we’ll be taking a closer look at the products already available for researchers. As the technology can be applied to generate many other mature cell types, more will be coming soon, including human skeletal myocytes, hepatocytes, immune cell types and other CNS cell types.

The first products developed using opti-ox™ are ioGlutamatergic Neurons and ioSkeletal Myocytes derived from hiPSCs, which are both available across Europe through tebu-bio. There will be more to follow…

To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering .

You can already access this new technology now through tebu-bio in Europe!  But first, let’s take a look at the technology in detail. If you like, you can also discover the available products here.

Since the discovery of reprogramming factors in 2006 and the boom of CRISPR gene editing strategies, induced pluripotent stem cells (iPSC) have emerged as new cellular models. The development of 3D cell culture technologies has also contributed to the generation of induced Pluripotent Stem Cell (iPSC) derived cells, with unique applications from patient-specific drug responses testing, to regenerative medicine. I would like to introduce in this post a selection of reagents in this domain, a combination of both routine and innovative quality reagents, that I consider as bringing something extra to your stem cell research projects.